Humasis Co Ltd
KOSDAQ:205470
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
995
2 040
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 6 499.82 KRW. Compared to the current market price of 1 029 KRW, Humasis Co Ltd is Undervalued by 84%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Humasis Co Ltd.
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Humasis Co Ltd
Balance Sheet Decomposition
Humasis Co Ltd
| Current Assets | 201.6B |
| Cash & Short-Term Investments | 186.9B |
| Receivables | 3.9B |
| Other Current Assets | 10.8B |
| Non-Current Assets | 130.3B |
| Long-Term Investments | 55.7B |
| PP&E | 68.9B |
| Intangibles | 4.6B |
| Other Non-Current Assets | 1.2B |
| Current Liabilities | 77.2B |
| Accounts Payable | 254.8m |
| Accrued Liabilities | 7.7B |
| Short-Term Debt | 5B |
| Other Current Liabilities | 64.3B |
| Non-Current Liabilities | 28.8B |
| Long-Term Debt | 848.1m |
| Other Non-Current Liabilities | 28B |
Free Cash Flow Analysis
Humasis Co Ltd
| KRW | |
| Free Cash Flow | KRW |
Earnings Waterfall
Humasis Co Ltd
|
Revenue
|
37.5B
KRW
|
|
Cost of Revenue
|
-32.3B
KRW
|
|
Gross Profit
|
5.2B
KRW
|
|
Operating Expenses
|
-14B
KRW
|
|
Operating Income
|
-8.8B
KRW
|
|
Other Expenses
|
-32.1B
KRW
|
|
Net Income
|
-41B
KRW
|
Profitability Score
Profitability Due Diligence
Humasis Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Humasis Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Humasis Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Humasis Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Humasis Co Ltd
Dividends
Current shareholder yield for Humasis Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Humasis Co Ltd stock under the Base Case scenario is 6 499.82 KRW.
Compared to the current market price of 1 029 KRW, Humasis Co Ltd is Undervalued by 84%.